High-performance liquid chromatography method for the determination and quantitation of arabinosylguanine triphosphate and fludarabine triphosphate in human cells.

[1]  J. Kurtzberg,et al.  Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[2]  E. Estey,et al.  Pharmacological and biochemical strategies to increase the accumulation of arabinofuranosylguanine triphosphate in primary human leukemia cells , 1997 .

[3]  J. Wilson,et al.  2-Amino-6-methoxypurine arabinoside: an agent for T-cell malignancies. , 1995, Cancer research.

[4]  W. Plunkett,et al.  Metabolism and actions of 2-chloro-9-(2-deoxy-2-fluoro-beta-D- arabinofuranosyl)-adenine in human lymphoblastoid cells. , 1995, Cancer research.

[5]  Elias S. J. Arnér,et al.  Substrate specificity of mitochondrial 2'-deoxyguanosine kinase. Efficient phosphorylation of 2-chlorodeoxyadenosine. , 1993, The Journal of biological chemistry.

[6]  R. Lewis,et al.  Phosphorylation of arabinosyl guanine by a mitochondrial enzyme of bovine liver. , 1989, Biochemical pharmacology.

[7]  A. Fridland,et al.  Metabolic basis of arabinonucleoside selectivity for human leukemic T- and B-lymphoblasts. , 1985, Cancer research.

[8]  P. Daddona,et al.  Metabolism and selective cytotoxicity of 9-beta-D-arabinofuranosylguanine in human lymphoblasts. , 1985, Cancer research.

[9]  W. Plunkett,et al.  Quantitation of 1-beta-D-arabinofuranosylcytosine 5'-triphosphate in the leukemic cells from bone marrow and peripheral blood of patients receiving 1-beta-D-arabinofuranosylcytosine therapy. , 1980, Cancer research.

[10]  R. Lewis,et al.  Partial purification and characterization of deoxyguanosine kinase from pig skin. , 1979, The Biochemical journal.

[11]  L. M. Beacham,et al.  Deoxycytidine kinase from calf thymus. Substrate and inhibitor specificity. , 1976, The Journal of biological chemistry.